Metabolomic Analysis Reveals That the Mechanism of Astaxanthin Improves the Osteogenic Differentiation Potential in Bone Marrow Mesenchymal Stem Cells

Figure 2

Expression of markers in BMSCs of the third generation. (a) For the expression of CD34, the positive rate was 0.92%; (b) for the expression of CD44, the positive rate was 96.11%; (c) for the expression of CD45, the positive rate was 0.95%; and (d) for the expression of CD90, the positive rate was 95.14%.

(a)

(b)

(c)

(d)